DIALYSIS FIRM COOKIE JAR! Executives COOKED BOOKS FOR PROFITS!

SEC v. Jonathan Wilcox, Jason Boucher, Karen Smith — U.S. Securities and Exchange Commission Litigation Release No. 26250, dated February 19, 2025.

The SEC charged American Renal Associates Holdings, Inc. (ARA) and three former executives with manipulating revenue to inflate financial performance. From 2017 to 2018, they allegedly used a "cookie jar" of revenue adjustments to meet targets, leading to overstated net income by over 30% in 2017 and 200% in early 2018. Final judgments have been entered against the individual defendants, imposing injunctions, officer/director bars, and monetary penalties.

In Plain English

Imagine a company that earns money from patients' insurance. Sometimes, they have to guess how much they'll get paid. This company had a special pot of money adjustments they could use. Instead of using these adjustments honestly when they happened, they saved them up. Then, when they needed to make their financial reports look good for that month or quarter, they'd pull money from this "cookie jar" to make it seem like they hit their goals, even when they didn't. This made their profits look much bigger than they really were.

Disclaimer: all facts are drawn from the SEC's own filings; the claims described are allegations unless and until a court rules or the parties settle, and some cases end in dismissal.

How the Alleged Scheme Worked

1. Estimating Revenue ARA recognized revenue from insurance reimbursements, which involved initial estimates of expected payments. These estimates were subject to change as actual cash was received.
2. Creating a 'Cookie Jar' Defendants allegedly created a 'cookie jar' of revenue adjustments. These were adjustments that should have been recorded but were instead held back, not until they were needed to meet financial targets.
3. Inflating Financial Performance From 2017 through at least November 2018, the defendants improperly manipulated these revenue adjustments to enhance ARA's financial performance and hit predetermined targets.
4. Misstating Financial Metrics The improper adjustments caused ARA to overstate its revenue, net income, and other key financial metrics throughout the relevant period.
5. Concealing the Scheme Defendants Boucher and Smith allegedly created false documents to mislead ARA's auditor and prevent the discovery of their improper accounting practices.
6. Company Restatement Following an SEC inquiry, ARA undertook an internal investigation and restated its financial statements for 2017 and the first three quarters of 2018.
7. Admitting Overstatements The restated financial statements reflected that ARA had overstated its net income by more than 30% for 2017 and by more than 200% for the first three quarters of 2018.
8. Identifying Weaknesses The restatement also acknowledged material weaknesses in ARA's internal controls related to revenue recognition, journal entry approval, and monitoring.

The Enforcement Action

In January 2025, the U.S. District Court for the District of Massachusetts entered final judgments against former CFO Jonathan Wilcox, former CFO Jason Boucher, and former Controller/VP of Finance Karen Smith. The judgments permanently enjoin them from violating securities laws, impose officer/director bars for Boucher and Smith, and order monetary relief including reimbursement to ARA, disgorgement, prejudgment interest, and civil penalties. The SEC's action alleged a fraudulent scheme to manipulate revenue from 2017 through November 2018, leading to a restatement of financial statements showing significant overstatements of net income.

Named in this action: Jonathan Wilcox, Jason Boucher, Karen Smith.

Original SEC litigation release ↗ · Browse all cases